Portfolio company
genemedicine
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops oncolytic adenovirus therapies for cancer patients and provides drug delivery systems and manufacturing services to the biotechnology sector.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
GenVec
This clinical-stage biotechnology company develops gene-based therapeutics and vaccines using a proprietary delivery platform for the biopharmaceutical industry.
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
Humane Genomics
This company develops synthetic oncolytic viral therapies to treat cancer patients by engineering viruses that selectively infect and destroy malignant cells.
Bitrobius Genetics
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
Forge Biologics
This company provides adeno-associated virus manufacturing services and develops gene therapies for biotechnology and pharmaceutical organisations.
Lentitek
This company develops manufacturing technologies for lentiviral vectors to help cell and gene therapy developers improve the production of advanced cancer treatments.
Kano
This biotechnology company develops and manufactures circular single-stranded DNA templates to improve the delivery of gene therapies for medical research and pharmaceutical partners.
Siren Biotechnology
The company develops adeno-associated virus immuno-gene therapies to treat solid tumour cancers for healthcare providers and patients.
